TY - JOUR
T1 - Microvesicular hyperplastic polyp and sessile serrated lesion of the large intestine
T2 - A biological continuum or separate entities?
AU - Bateman, Adrian C.
AU - Booth, Adam L.
AU - Gonzalez, Raul S.
AU - Shepherd, Neil A.
N1 - Publisher Copyright:
© 2023 BMJ Publishing Group. All rights reserved.
PY - 2023/7/1
Y1 - 2023/7/1
N2 - The range of lesions with a serrated appearance within the large intestine has expanded and become more complex over the last 30 years. The majority of these were previously known as metaplastic polyps but are today called hyperplastic polyps (HPs). HPs show two main growth patterns: microvesicular and goblet cell-rich. The former type shows morphological and molecular similarities (eg, BRAF mutations) to the more recently described sessile serrated lesion (SSL). In this review, we debate whether these lesions represent a biological spectrum or separate entities. Whichever view is held, microvesicular HPs and SSLs are distinct from the goblet cell-rich HP and the traditional serrated adenoma (TSA), which may themselves share molecular changes (eg, KRAS mutations), with the goblet cell-rich HP representing a precursor to the TSA. Both SSLs and the goblet cell-rich HP-TSA pathway are routes to colorectal cancer within the serrated pathway and overlaps between them can occur, for example, a (BRAF-mutated) TSA may arise from an SSL.
AB - The range of lesions with a serrated appearance within the large intestine has expanded and become more complex over the last 30 years. The majority of these were previously known as metaplastic polyps but are today called hyperplastic polyps (HPs). HPs show two main growth patterns: microvesicular and goblet cell-rich. The former type shows morphological and molecular similarities (eg, BRAF mutations) to the more recently described sessile serrated lesion (SSL). In this review, we debate whether these lesions represent a biological spectrum or separate entities. Whichever view is held, microvesicular HPs and SSLs are distinct from the goblet cell-rich HP and the traditional serrated adenoma (TSA), which may themselves share molecular changes (eg, KRAS mutations), with the goblet cell-rich HP representing a precursor to the TSA. Both SSLs and the goblet cell-rich HP-TSA pathway are routes to colorectal cancer within the serrated pathway and overlaps between them can occur, for example, a (BRAF-mutated) TSA may arise from an SSL.
KW - COLON
KW - Colorectal Neoplasms
KW - Gastrointestinal Neoplasms
UR - http://www.scopus.com/inward/record.url?scp=85152132502&partnerID=8YFLogxK
U2 - 10.1136/jcp-2023-208783
DO - 10.1136/jcp-2023-208783
M3 - Review article
C2 - 36927607
AN - SCOPUS:85152132502
SN - 0021-9746
VL - 76
SP - 429
EP - 434
JO - Journal of Clinical Pathology
JF - Journal of Clinical Pathology
IS - 7
ER -